Literature DB >> 4047180

Antinociceptive action of tizanidine in mice and rats.

T Kameyama, T Nabeshima, A Sugimoto, K Matsuno, S Yamada.   

Abstract

The antinociceptive action of tizanidine [5-chloro-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole], a centrally acting muscle relaxant, was evaluated after subcutaneous or peroral administration in mice and rats. Tizanidine strongly inhibited the writhing response induced by acetic acid, phenyl-p-benzoquinone and acetylcholine in mice, and its potency was found to be greater than that of morphine. Tizanidine showed antinociceptive action like morphine not only in tail pressure and electrical stimulation tests in mice but also in tail-flick tests in mice and rats. The antinociceptive action of tizanidine was unaffected by pretreatment with naloxone. These findings suggest that tizanidine develops relatively strong antinociceptive action by a nonopioid mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047180     DOI: 10.1007/BF00499900

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats.

Authors:  P A JANSSEN; C J NIEMEGEERS; J G DONY
Journal:  Arzneimittelforschung       Date:  1963-06

2.  A method for evaluating both non-narcotic and narcotic analgesics.

Authors:  E SIEGMUND; R CADMUS; G LU
Journal:  Proc Soc Exp Biol Med       Date:  1957 Aug-Sep

3.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

4.  A method for testing analgesics in mice.

Authors:  R S GREWAL
Journal:  Br J Pharmacol Chemother       Date:  1952-09

5.  A comparison of heat and pressure analgesiometric methods in rats.

Authors:  A F GREEN; P A YOUNG
Journal:  Br J Pharmacol Chemother       Date:  1951-12

6.  [Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)].

Authors:  E Ringwald; S J Campean; F Gerstenbrand; A Lorincz; P Lörincz; H P Ludin
Journal:  Nervenarzt       Date:  1977-07       Impact factor: 1.214

7.  The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent.

Authors:  A C Sayers; H R Bürki; E Eichenberger
Journal:  Arzneimittelforschung       Date:  1980
  7 in total
  4 in total

Review 1.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

2.  Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.

Authors:  Herbert R Henney; Michael Chez
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 3.  Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?

Authors:  Frederick G Freitag
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test.

Authors:  Handong Ouyang; Peizong Wang; Wan Huang; Qiang Li; Bilin Nie; Weian Zeng
Journal:  Pain Res Manag       Date:  2015-09-10       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.